Achieving Sustainable Healthcare Through Deprescribing

Overview

Journal Cochrane Database Syst Rev

Publisher Wiley

Specialties General Medicine
Health Services

Date 2022 Oct 4

PMID 36194519

Authors

Danijela Gnjidic

Minna Johansson

Dina Muscat Meng

Barbara Farrell

Aili Langford

Emily Reeve

Affiliations

Soon will be listed here.

Citing Articles

Behavioral Determinants of Older Adults' and Caregivers' Willingness to Deprescribe: A Systematic Review.

Alves Jorge S, Van den Broucke S, Koumba Maguena R, Spinewine A Public Health Nurs. 2024; 42(2):1084-1114.

PMID: 39740058 PMC: 11895417. DOI: 10.1111/phn.13516.

[Drug therapy for arterial hypertension and atrial fibrillation in frail patients : Are there any new insights and recommendations?].

Muller-Werdan U Inn Med (Heidelb). 2024; 65(5):517-523.

PMID: 38456903 DOI: 10.1007/s00108-024-01681-8.

Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review.

Sheppard J, Benetos A, Bogaerts J, Gnjidic D, McManus R Curr Hypertens Rep. 2024; 26(5):225-236.

PMID: 38305846 PMC: 11153298. DOI: 10.1007/s11906-024-01293-5.

Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.

van Poelgeest E, Seppala L, Bahat G, Ilhan B, Mair A, van Marum R Eur Geriatr Med. 2023; 14(6):1195-1209.

PMID: 37812379 PMC: 10754739. DOI: 10.1007/s41999-023-00872-0.

Guideline-Directed Medical Therapies for Heart Failure with a Reduced Ejection Fraction in Older Adults: A Narrative Review on Efficacy, Safety and Timeliness.

Van der Linden L, Hias J, Walgraeve K, Petrovic M, Tournoy J, Vandenbriele C Drugs Aging. 2023; 40(8):691-702.

PMID: 37452262 DOI: 10.1007/s40266-023-01046-0.

References

Reeve E, Jordan V, Thompson W, Sawan M, Todd A, Gammie T . Withdrawal of antihypertensive drugs in older people. Cochrane Database Syst Rev. 2020; 6:CD012572. PMC: 7387859. DOI: 10.1002/14651858.CD012572.pub2. View

Verhoef L, van den Bemt B, van der Maas A, Vriezekolk J, Hulscher M, van den Hoogen F . Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity. Cochrane Database Syst Rev. 2019; 5:CD010455. PMC: 6534285. DOI: 10.1002/14651858.CD010455.pub3. View

Gnjidic D, Reeve E . Deprescribing: What do we know, and where to next?. Br J Clin Pharmacol. 2020; 87(3):722-724. DOI: 10.1111/bcp.14525. View

Bayliss E, Albers K, Gleason K, Pieper L, Boyd C, Campbell N . Recommendations for outcome measurement for deprescribing intervention studies. J Am Geriatr Soc. 2022; 70(9):2487-2497. PMC: 9489620. DOI: 10.1111/jgs.17894. View

Boyapati R, Torres J, Palmela C, Parker C, Silverberg O, Upadhyaya S . Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease. Cochrane Database Syst Rev. 2018; 5:CD012540. PMC: 6494506. DOI: 10.1002/14651858.CD012540.pub2. View